These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 15893841)

  • 1. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
    Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
    Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
    Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
    Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
    Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.
    Fernandez M; Vizzutti F; Garcia-Pagan JC; Rodes J; Bosch J
    Gastroenterology; 2004 Mar; 126(3):886-94. PubMed ID: 14988842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
    Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
    Pérez-Páramo M; Muñoz J; Albillos A; Rossi I; Alvarez-Mon M; Ortiz Berrocal J
    Rev Esp Med Nucl; 1998; 17(4):294-301. PubMed ID: 9721346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.
    Tiani C; Garcia-Pras E; Mejias M; de Gottardi A; Berzigotti A; Bosch J; Fernandez M
    J Hepatol; 2009 Feb; 50(2):296-305. PubMed ID: 19070926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.
    Abraldes JG; Iwakiri Y; Loureiro-Silva M; Haq O; Sessa WC; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G980-7. PubMed ID: 16603731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
    Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
    Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.
    Roman CD; Choy H; Nanney L; Riordan C; Parman K; Johnson D; Beauchamp RD
    J Surg Res; 2002 Jun; 105(1):43-7. PubMed ID: 12069500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
    Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M
    J Hepatol; 2009 Nov; 51(5):865-73. PubMed ID: 19726100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term administration of octreotide in portal vein-stenosed rats.
    Lin HC; Yang MC; Hou MC; Li SM; Huang YT; Yu PC; Tsai YT; Lee SD
    Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
    Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
    World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.